18 employees
Elixiron Immunotherapeutics is a company developing therapeutics for cancer, rare, and inflammatory disorders
2017
Elixiron Immunotherapeutics raised undisclosed on August 23, 2021
Investors: Taiwania Capital and Fubon Financial Holding Co., Ltd. 富邦金控